10
Participants
Start Date
September 9, 2019
Primary Completion Date
June 22, 2023
Study Completion Date
June 22, 2023
Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10)
Burst SCS implies high frequency SCS treatment in intermittent packets with stimulation below detection level. Abbott BurstDR at default setting: Pulse width 1000 microseconds, frequency 500 Hz/40 Hz, continuous stimulation (no cycling). Pulse amplitude at maximum 60% of sensory threshold
Oslo University Hospital, Department of Pain Management and Research, Oslo
Uppsala University Hospital, Multidisciplinary Pain Center, Uppsala
Uppsala University Hospital
OTHER
Oslo University Hospital
OTHER